EHA 2026 | What are the key findings from the phase I ANTLER trial in R/R B-cell NHL?
During the European Hematology Association (EHA) 2026 Congress, June 11–14, 2025, Stockholm, SE, the Lymphoma Hub spoke with Stephen Schuster, University of Pennsylvania, Philadelphia, US. We asked, What are the key findings from the phase I ANTLER trial in R/R B-cell NHL? This educational resource is independently supported by Caribou Biosciences. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.
▶︎
EHA 2026 | Recent findings from the phase I NX-5948-301 trial of bexobrutideg in CLL
▶︎
Glofit-GemOx vs R-GemOx in patients with R/R DLBCL: Results from the STARGLO
▶︎
ALPHA3 study: first-line cema-cel consolidation for MRD-positive LBCL after standard therapy
▶︎
ASH 2025 | Key highlights in lymphoma and CLL
▶︎
Uruguay – Kap Verde Highlights | Gruppe H, FIFA WM 2026 | sportstudio
▶︎
Virginia Emergency Physicians Replaced By Private Equity
▶︎
How US Air Force B 52 Pilot Performed an Emergency Takeoff at Full Speed
▶︎
Watch Ukrainian Drones OBLITERATE a Russian Jet
▶︎
Welcome to hell: Inside the Colorado supermax prison
▶︎
Warner to RFK Jr.: How can you be that ignorant?
▶︎
Golden Retriever Meets Completely Broken Rescue for the First Time
▶︎
Lower Infections with Elranatamab in Multiple Myeloma in Real-World Settings | EHA 2026
▶︎
Neurologist Warns: If Your NAILS Look Like THIS After 60 Your Body May be Hiding 4 Diseases| Mandell
▶︎
'CANCER OCCURRED near injection sites...': Bombshell testimony ‘EXPOSES’ COVID-19 vaccine injuries
▶︎
Belgien – Iran Highlights | Gruppe G, FIFA WM 2026 | sportstudio
▶︎
ASH 2025 | EPCORE FL-1 phase III primary results: Epcoritamab + R2 vs R2 alone for R/R FL
▶︎
NephCure U: A C3G Update
▶︎
I GOT MY BRAIN SCANNED FOR AUTISM as a functional doctor!
▶︎